Founded with a mission to address industrial infrastructure challenges through synthetic biology, Novophage focuses on developing green, effective anti-biofilm solutions. The company targets biofilms, which are slimy bacterial communities that cause significant issues like heat transfer inefficiencies, corrosion, biofouling, and diseases. Novophage’s innovative products aim to enhance energy efficiency and prolong the lifespan of industrial infrastructure without the use of toxic or environmentally damaging chemicals.

Notable figures associated with Novophage include experts in synthetic biology and industrial engineering, although specific names are not publicly disclosed. The company has attracted attention from investors interested in sustainable industrial solutions. Key achievements include the development of a first-in-class anti-biofilm product that has shown promising results in initial trials. Novophage's impact lies in its potential to save billions in economic costs while promoting environmentally friendly practices in industrial maintenance.